Boston Partners Purchases 12,144 Shares of The Joint Corp. (NASDAQ:JYNT)

Posted by on Feb 15th, 2023

Boston Partners lifted its position in shares of The Joint Corp. (NASDAQ:JYNT – Get Rating) by 63.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,184 shares of the company’s stock after buying an additional 12,144 shares during the quarter. Boston Partners owned approximately 0.21% of Joint worth $490,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. UBS Asset Management Americas Inc. grew its position in shares of Joint by 6.0% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 10,467 shares of the company’s stock worth $160,000 after buying an additional 597 shares in the last quarter. First Light Asset Management LLC boosted its position in Joint by 1.9% during the first quarter. First Light Asset Management LLC now owns 56,498 shares of the company’s stock valued at $1,999,000 after purchasing an additional 1,046 shares in the last quarter. Credit Suisse AG boosted its position in Joint by 11.3% during the second quarter. Credit Suisse AG now owns 10,842 shares of the company’s stock valued at $167,000 after purchasing an additional 1,100 shares in the last quarter. New York State Teachers Retirement System boosted its position in Joint by 18.0% during the third quarter. New York State Teachers Retirement System now owns 7,877 shares of the company’s stock valued at $124,000 after purchasing an additional 1,203 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Joint by 8.2% during the first quarter. JPMorgan Chase & Co. now owns 16,212 shares of the company’s stock valued at $574,000 after purchasing an additional 1,228 shares in the last quarter. Institutional investors own 88.13% of the company’s stock.

Joint Price Performance

Shares of JYNT stock opened at $15.30 on Wednesday. The Joint Corp. has a 1-year low of $12.85 and a 1-year high of $56.62. The stock’s 50-day moving average is $16.34 and its 200 day moving average is $16.82. The company has a market cap of $222.31 million, a P/E ratio of 306.00 and a beta of 1.32. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.87 and a quick ratio of 0.87.

Insiders Place Their Bets

In other Joint news, major shareholder Bandera Partners Llc purchased 40,339 shares of the stock in a transaction on Tuesday, January 3rd. The stock was acquired at an average price of $13.45 per share, with a total value of $542,559.55. Following the completion of the acquisition, the insider now owns 2,570,087 shares in the company, valued at $34,567,670.15. The acquisition was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 3.50% of the company’s stock.

Joint Company Profile

(Get Rating)

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit.

Read More

Institutional Ownership by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.